↓ Skip to main content

Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study

Overview of attention for article published in Frontiers in oncology, February 2024
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
2 Mendeley